Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AGENUS INC Insider Profile
11 Followers
AGENUS INC, Ten Percent Owner at MiNK Therapeutics, holds 21.77M shares in MiNK Therapeutics (Ticker: INKT). Most recently, AGENUS INC Bought $22,975 shares of MiNK Therapeutics on Oct 16, 2023 for an estimated value of 25.24K.
Profitable Transactions
0 out of 7 Profitable Transactions
Average Return
-36.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that AGENUS INC holds in companies
Most Profitable Insider Trade
The most profitable trade made by AGENUS INC
AGENUS INC's Trading History
List of latest transactions for each holding click on a transaction to see AGENUS INC's performance on stock
You May Also Like
AGENUS INC insider profile FAQ
What is the percentage of profitable transactions made by AGENUS INC?
The percentage of profitable transactions made by AGENUS INC is 0%.
What is the average return per transaction made by AGENUS INC?
The average return per transaction made by AGENUS INC is -36.50%.
What stocks does AGENUS INC hold?
AGENUS INC holds: INKT stocks.
What was AGENUS INC’s latest transaction?
AGENUS INC latest transaction was an Informative Buy of $25.24K.
What was AGENUS INC's most profitable transaction?
AGENUS INC’s most profitable transaction was an Informative Buy of INKT stock on October 16, 2023. The return on the trade was -10.90%.
What is AGENUS INC's role in MiNK Therapeutics?
AGENUS INC's role in MiNK Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.